Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage

View More View Less
  • 1 Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, and Laboratory of Physiologic Studies, National Institute of Alcohol Abuse and Alcoholism; and Radiation Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota; and Department of Neurosurgery, Johann Wolfgang-Goethe University, Frankfurt/Main, Germany
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object. Decreased availability of nitric oxide (NO) has been proposed to evoke delayed cerebral vasospasm after subarachnoid hemorrhage (SAH). Asymmetric dimethyl-l-arginine (ADMA) inhibits endothelial NO synthase (eNOS) and, therefore, may be responsible for decreased NO availability in cases of cerebral vasospasm. The goal of this study was to determine whether ADMA levels are associated with cerebral vasospasm in a primate model of SAH.

Methods. Twenty-two cynomolgus monkeys (six control animals and 16 with SAH) were used in this study. The levels of ADMA, l-arginine, l-citrulline, nitrites, and nitrates in cerebrospinal fluid (CSF) and serum were determined on Days 0, 7, 14, and 21 following onset of SAH. Cerebral arteriography was performed to assess the degree of vasospasm. Western blot analyses of the right and left middle cerebral arteries (MCAs) were performed to assess the expression of eNOS, type I protein—arginine methyl transferase (PRMT1) and dimethylarginine dimethylaminohydrolase (DDAH2).

Cerebrospinal fluid levels of ADMA remained unchanged in the control group (six animals) and in animals with SAH that did not have vasospasm (five animals; p = 0.17), but the levels increased in animals with vasospasm (11 animals) on Day 7 post-SAH (p < 0.01) and decreased on Days 14 through 21 (p < 0.05). Cerebrospinal fluid levels of ADMA correlated directly with the degree of vasospasm (correlation coefficient = 0.7, p = 0.0001; 95% confidence interval: 0.43–0.83). Levels of nitrite and nitrate as well as those of l-citrulline in CSF were decreased in animals with vasospasm. Furthermore, DDAH2 expression was attenuated in the right spastic MCA on Day 7 post-SAH, whereas eNOS and PRMT1 expression remained unchanged.

Conclusions. Changes in the CSF levels of ADMA are associated with the development and resolution of vasospasm found on arteriograms after SAH. The results indicate that endogenous inhibition of eNOS by ADMA may be involved in the development of delayed cerebral vasospasm. Inhibition of ADMA production may provide a new therapeutic approach for cerebral vasospasm after SAH.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1.

    Afshar JK, , Pluta RM, & Boock RJ, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118122, 1995 Afshar JK, Pluta RM, Boock RJ, et al: Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83:118–122, 1995

    • Search Google Scholar
    • Export Citation
  • 2.

    Bidlingmeyer BA, , Cohen SA, & Tarvin TL, et al: Rapid analysis of amino acids using pre-column derivatization. J Chromatogr 336:93104, 1984 Bidlingmeyer BA, Cohen SA, Tarvin TL, et al: Rapid analysis of amino acids using pre-column derivatization. J Chromatogr 336:93–104, 1984

    • Search Google Scholar
    • Export Citation
  • 3.

    Boger RH, , Sydow K, & Borlak J, et al: LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87:99105, 2000 Boger RH, Sydow K, Borlak J, et al: LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87:99–105, 2000

    • Search Google Scholar
    • Export Citation
  • 4.

    Cooke JP: Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20:20322037, 2000 Cooke JP: Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20:2032–2037, 2000

    • Search Google Scholar
    • Export Citation
  • 5.

    Espinosa F, , Weir B, & Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part I: Clinical and radiological findings. J Neurosurg 60:11671175, 1984 Espinosa F, Weir B, Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part I: Clinical and radiological findings. J Neurosurg 60:1167–1175, 1984

    • Search Google Scholar
    • Export Citation
  • 6.

    Faraci F, , Brian JE Jr, & Heistad DD: Response of cerebral vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 269:H1522H1527, 1995 Faraci F, Brian JE Jr, Heistad DD: Response of cerebral vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 269:H1522–H1527, 1995

    • Search Google Scholar
    • Export Citation
  • 7.

    Furchgott R, & Zawadzki J: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373376, 1980 Furchgott R, Zawadzki J: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376, 1980

    • Search Google Scholar
    • Export Citation
  • 8.

    Goksel HM, , Ozum U, & Oztoprak I: The therapeutic effect of continuous intracisternal L-Arginine infusion on experimental cerebral vasospasm. Acta Neurochir 143:277285, 2001 Goksel HM, Ozum U, Oztoprak I: The therapeutic effect of continuous intracisternal L-Arginine infusion on experimental cerebral vasospasm. Acta Neurochir 143:277–285, 2001

    • Search Google Scholar
    • Export Citation
  • 9.

    Hino A, , Tokuyama Y, & Weir B, et al: Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 39:562568, 1996 Hino A, Tokuyama Y, Weir B, et al: Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 39:562–568, 1996

    • Search Google Scholar
    • Export Citation
  • 10.

    Iadecola C: Regulation of the cerebral microcirculation during neural acitvity: is nitric oxide the missing link. Trends Neurosurg 16:206214, 1993 Iadecola C: Regulation of the cerebral microcirculation during neural acitvity: is nitric oxide the missing link. Trends Neurosurg 16:206–214, 1993

    • Search Google Scholar
    • Export Citation
  • 11.

    Ito A, , Tsao PS, & Adimoolam S, et al: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99:30923095, 1999 Ito A, Tsao PS, Adimoolam S, et al: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99:3092–3095, 1999

    • Search Google Scholar
    • Export Citation
  • 12.

    Iuliano B, , Pluta RM, & Jung C, et al: Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg 100:287294, 2004 Iuliano B, Pluta RM, Jung C, et al: Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg 100:287–294, 2004

    • Search Google Scholar
    • Export Citation
  • 13.

    Kajita Y, , Suzuki Y, & Oyama H, et al: Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 80:476483, 1994 Kajita Y, Suzuki Y, Oyama H, et al: Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 80:476–483, 1994

    • Search Google Scholar
    • Export Citation
  • 14.

    Kassell NF, , Torner JC, & Haley EC Jr: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:1836, 1990 Kassell NF, Torner JC, Haley EC Jr: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18–36, 1990

    • Search Google Scholar
    • Export Citation
  • 15.

    Kasuya H, , Weir BK, & Nakane M, et al: Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 82:250255, 1995 Kasuya H, Weir BK, Nakane M, et al: Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 82:250–255, 1995

    • Search Google Scholar
    • Export Citation
  • 16.

    Kim P, , Schini VB, & Sundt TM Jr, et al: Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 70:248256, 1992 Kim P, Schini VB, Sundt TM Jr, et al: Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 70:248–256, 1992

    • Search Google Scholar
    • Export Citation
  • 17.

    Kimoto M, , Whitley GS, & Tsuji H, et al: Detection of Ng, Ng-dimethylarginine dimethylaminohydrolase in human tissue using a monoclonal antibody. J Biochem 117:237238, 1995 Kimoto M, Whitley GS, Tsuji H, et al: Detection of Ng, Ng-dimethylarginine dimethylaminohydrolase in human tissue using a monoclonal antibody. J Biochem 117:237–238, 1995

    • Search Google Scholar
    • Export Citation
  • 18.

    Leiper JM, , Santa Maria J, & Chubb A, et al: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distribution and homology with microbial arginine deiminases. Biochem J 343:209214, 1999 Leiper JM, Santa Maria J, Chubb A, et al: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distribution and homology with microbial arginine deiminases. Biochem J 343:209–214, 1999

    • Search Google Scholar
    • Export Citation
  • 19.

    MacAllister RJ, , Parry H, & Kimoto M, et al: Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119:15331540, 1996 MacAllister RJ, Parry H, Kimoto M, et al: Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119:1533–1540, 1996

    • Search Google Scholar
    • Export Citation
  • 20.

    McGirt MJ, , Lynch JR, & Parra A: Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33:29502956, 2002 McGirt MJ, Lynch JR, Parra A: Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33:2950–2956, 2002

    • Search Google Scholar
    • Export Citation
  • 21.

    Ogawa T, , Kimoto M, & Sasaoka K: Purification and properties of a new enzyme NGNG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264:1020510209, 1989 Ogawa T, Kimoto M, Sasaoka K: Purification and properties of a new enzyme NGNG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264:10205–10209, 1989

    • Search Google Scholar
    • Export Citation
  • 22.

    Park KW, , Metais C, & Dai HB, et al: Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg 92:990996, 2001 Park KW, Metais C, Dai HB, et al: Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg 92:990–996, 2001

    • Search Google Scholar
    • Export Citation
  • 23.

    Pettersson A, , Uggla L, & Backman V: Determination of dimethylated arginines in human plasma by high-performance lipid chromatography. J Chromatogr B Biomed Sci Appl 692:257262, 1997 Pettersson A, Uggla L, Backman V: Determination of dimethylated arginines in human plasma by high-performance lipid chromatography. J Chromatogr B Biomed Sci Appl 692:257–262, 1997

    • Search Google Scholar
    • Export Citation
  • 24.

    Pluta RM, , Afshar JK, & Thompson BG, et al: Increases cerebral blood flow but no reversal or prevention vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. J Neurosurg 92:121126, 2000 Pluta RM, Afshar JK, Thompson BG, et al: Increases cerebral blood flow but no reversal or prevention vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. J Neurosurg 92:121–126, 2000

    • Search Google Scholar
    • Export Citation
  • 25.

    Pluta RM, , Oldfield EH, & Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746751, 1997 Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746–751, 1997

    • Search Google Scholar
    • Export Citation
  • 26.

    Pluta RM, , Thompson BG, & Afshar JK, et al: Nitric oxide and vasospasm. Acta Neurochir (Suppl) 77:6772, 2001 Pluta RM, Thompson BG, Afshar JK, et al: Nitric oxide and vasospasm. Acta Neurochir (Suppl) 77:67–72, 2001

    • Search Google Scholar
    • Export Citation
  • 27.

    Pluta RM, , Thompson BG, & Dawson TM, et al: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648654, 1996 Pluta RM, Thompson BG, Dawson TM, et al: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648–654, 1996

    • Search Google Scholar
    • Export Citation
  • 28.

    Schievink WI: Intracranial aneurysms. N Engl J Med 336:2840, 1997 Schievink WI: Intracranial aneurysms. N Engl J Med 336:28–40, 1997

    • Search Google Scholar
    • Export Citation
  • 29.

    Segarra G, , Medina P, & Ballester RM, et al: Effects of guanidino compounds on human cerebral arteries. Stroke 30:22062211, 1999 Segarra G, Medina P, Ballester RM, et al: Effects of guanidino compounds on human cerebral arteries. Stroke 30:2206–2211, 1999

    • Search Google Scholar
    • Export Citation
  • 30.

    Sobey CG: Cerebrovascular dysfunction after subarachnoid hemorrhage: novel mechanisms and directions for therapy. Clin Exp Pharmacol Physiol 28:926929, 2001 Sobey CG: Cerebrovascular dysfunction after subarachnoid hemorrhage: novel mechanisms and directions for therapy. Clin Exp Pharmacol Physiol 28:926–929, 2001

    • Search Google Scholar
    • Export Citation
  • 31.

    Sobey CG, & Faraci FM: Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867876, 1998 Sobey CG, Faraci FM: Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867–876, 1998

    • Search Google Scholar
    • Export Citation
  • 32.

    Suzuki Y, , Kajita Y, & Oyama H, et al: Dysfunction of nitric oxide in the spastic basilar arteries after subarachnoid hemorrhage. J Auton Nerv Syst 49 (Suppl):S8387, 1994 Suzuki Y, Kajita Y, Oyama H, et al: Dysfunction of nitric oxide in the spastic basilar arteries after subarachnoid hemorrhage. J Auton Nerv Syst 49 (Suppl):S83–87, 1994

    • Search Google Scholar
    • Export Citation
  • 33.

    Tang J, , Gary JD, & Clarke S, et al: PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J Biol Chem 273:1693516945, 1998 Tang J, Gary JD, Clarke S, et al: PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J Biol Chem 273:16935–16945, 1998

    • Search Google Scholar
    • Export Citation
  • 34.

    Tang J, , Kao PN, & Herschman HR: Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J Biol Chem 275:1986619876, 2000 Tang J, Kao PN, Herschman HR: Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J Biol Chem 275:19866–19876, 2000

    • Search Google Scholar
    • Export Citation
  • 35.

    Teerlink T, , Nijveldt R, & deJong S, et al: Determination of arginine, asymmetric dimethylarginine, and symmetric dimethy l-arginine in human plasma and other biological samples by high-performance lipid chromatography. Anal Biochem 303:131137, 2002 Teerlink T, Nijveldt R, deJong S, et al: Determination of arginine, asymmetric dimethylarginine, and symmetric dimethy l-arginine in human plasma and other biological samples by high-performance lipid chromatography. Anal Biochem 303:131–137, 2002

    • Search Google Scholar
    • Export Citation
  • 36.

    Thompson BG, , Pluta RM, & Girton ME, et al: Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg 84:7178, 1996 Thompson BG, Pluta RM, Girton ME, et al: Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg 84:71–78, 1996

    • Search Google Scholar
    • Export Citation
  • 37.

    Toda N, , Tanaka T, & Ayajiki K, et al: Cerebral vasodilatation induced by stimulation of the sphenopalatine ganglion and greater petrosal nerve in anesthetized monkeys. Neuroscience 96:393398, 2000 Toda N, Tanaka T, Ayajiki K, et al: Cerebral vasodilatation induced by stimulation of the sphenopalatine ganglion and greater petrosal nerve in anesthetized monkeys. Neuroscience 96:393–398, 2000

    • Search Google Scholar
    • Export Citation
  • 38.

    Tran CT, , Fox MF, & Vallance P, et al: Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 68:101105, 2000 Tran CT, Fox MF, Vallance P, et al: Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 68:101–105, 2000

    • Search Google Scholar
    • Export Citation
  • 39.

    Vallance P, & Chan N: Endothelial dysfunction and nitric oxide: clinical relevance. Heart 85:342350, 2001 Vallance P, Chan N: Endothelial dysfunction and nitric oxide: clinical relevance. Heart 85:342–350, 2001

    • Search Google Scholar
    • Export Citation
  • 40.

    Vallance P, , Leone A, & Calver A, et al: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572575, 1992 Vallance P, Leone A, Calver A, et al: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572–575, 1992

    • Search Google Scholar
    • Export Citation
  • 41.

    Vallance P, , Leone A, & Calver A, et al: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20 (Suppl 12):S60S62, 1992 Vallance P, Leone A, Calver A, et al: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20 (Suppl 12):S60–S62, 1992

    • Search Google Scholar
    • Export Citation
  • 42.

    Weir B, , Grace M, & Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173181, 1978 Weir B, Grace M, Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173–181, 1978

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 469 104 17
Full Text Views 221 9 0
PDF Downloads 109 7 0
EPUB Downloads 0 0 0